基于Banff分级的组织学慢性化指数与肾移植受者抗体介导排斥反应中移植物丢失相关
研究纳入147例有供者特异性抗体并接受治疗的活跃型或慢性活跃型抗体介导排斥反应(AMR)肾移植受者,构建基于Banff评分的活动性指数与慢性化指数,发现慢性化指数≥4与移植物丢失显著相关且独立于其他因素,并在巴黎Necker医院61例独立队列中验证。
要点
- 慢性化指数为间质纤维化、肾小管萎缩、慢性血管病变与慢性肾小球病变评分之和(后者加倍),最高15分。
- 慢性化指数≥4是预测移植物丢失的最佳阈值,且独立于eGFR、AMR类型、供者特异性抗体类型等因素。
- 活动性指数为肾小球炎、管周毛细血管炎、动脉炎与C4d评分之和(最高12分),总体与移植物丢失无关。
核心结论
- 慢性化指数≥4与活跃型或慢性活跃型AMR患者的移植物丢失显著相关,且独立于其他相关参数,并在独立队列中验证。
- 作者认为慢性化指数可能作为简化AMR患者决策的有价值方法。
研究设计与样本
- 研究纳入147例有供者特异性抗体并接受AMR治疗的活跃型或慢性活跃型AMR肾移植受者,构建基于Banff活检评分的活动性指数与慢性化指数并分析其与移植物存活的关系。
- 另在巴黎Necker医院61例独立队列中验证慢性化指数≥4与移植物丢失的关联。
主要发现
- 活动性指数为Banff肾小球炎(g)、管周毛细血管炎(ptc)、动脉炎(v)与C4d评分之和,最高12分,总体与移植物丢失无关。
- 慢性化指数为间质纤维化(ci)、肾小管萎缩(ct)、慢性血管病变(cv)与慢性肾小球病变(cg)评分之和(cg加倍),最高15分。
- 慢性化指数与移植物丢失显著相关,预测移植物丢失的最佳阈值为≥4。
- 慢性化指数≥4与移植物丢失的关联独立于活检时eGFR、慢性活跃型(对比活跃型)AMR、新发(对比持续/反弹)供者特异性抗体、Banff(g+ptc)评分、合并T细胞介导排斥反应及活检后供者特异性抗体下降。
- 慢性化指数≥4与移植物丢失的关联在巴黎Necker医院61例独立队列中得到确认。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Antibody-mediated rejection (AMR) is the major cause of graft loss in kidney transplant recipients. The Banff classification defines two classes of AMR, active and chronic active but over time this classification has become increasingly complex. To simplify the approach to AMR, we developed activity and chronicity indices based on kidney transplant biopsy findings and examined their association with graft survival in 147 patients with active or chronic active AMR, all of whom had donor-specific antibodies and were treated for AMR. The activity index was determined as the sum of Banff glomerulitis (g), peritubular capillaritis (ptc), arteritis (v) and C4d scores, with a maximum score of 12. The chronicity index was the sum of interstitial fibrosis (ci), tubular atrophy (ct), chronic vasculopathy (cv), and chronic glomerulopathy (cg) scores, the latter doubled, with a maximum score of 15. While the activity index was generally not associated with graft loss, the chronicity index was significantly associated with graft loss with an optimal threshold value of 4 or greater for predicting graft loss. The association of the chronicity index of 4 or greater with graft loss was independent of other parameters associated with graft loss, including the estimated glomerular filtration rate at the time of biopsy, chronic active (versus active) AMR, AMR with de novo (versus persistent/rebound) donor-specific antibodies, Banff (g+ptc) scores, concurrent T cell-mediated rejection and donor-specific antibody reduction post-biopsy. The association of the chronicity index of 4 or greater with graft loss was confirmed in an independent cohort of 61 patients from Necker Hospital, Paris. Thus, our findings suggest that the chronicity index may be valuable as a simplified approach to decision-making in patients with AMR.
引用
- Haas M, Mirocha J, Huang E, et al. A Banff-based histologic chronicity index is associated with graft loss in patients with a kidney transplant and antibody-mediated rejection. Kidney Int. 2022. PMID: 36332728. doi:10.1016/j.kint.2022.09.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。